EGR-1, the Reluctant Suppression Factor

Critical Reviews in Oncogenesis

Volumn 7, Issue 1-2, 1996, Pages 101-125

  Liu, Chaoting ^a   Calogero, Antonella ^b   Ragona, Guiseppe ^b   Adamson, Eileen ^c   Mercola, Dan ^c,d  

^a SIDNEY KIMMEL CANCER CENTER   (United States)

^b IRCCS NEUROMED   (Italy)

^c BURNHAM INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; EGR 1; Sp1; Transformation; Transforming growth factor 1; WT1

Indexed keywords

TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

CELL DIFFERENTIATION; GENETIC REGULATION; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELL TRANSFORMATION, VIRAL; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; HUMANS; IMMEDIATE-EARLY PROTEINS; NEOPLASMS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030429532     PISSN: 08939675     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevoncog.v7.i1-2.70     Document Type: Article

References (160)

1. Ackerman, S. L., A. G. Minder, G. T. Williams, C. Bobonis, and C.-Y. Yeung: Functional significance of an over-lapping consensus binding motif for Sp1 and Zif268 in the murine adenosine deaminase gene promoter. Proc. Natl. Acad. Sci. U.S.A., 88:7523-7527 (1991).
2. Akagi, T., H. Ono, and K. Shimotohno: Characterization of T cells immortalized by Tax1 of human T-cell leukemia virus type 1. Blood, 86:4243-4249 (1995).
3. Alexandrow, M. G. and H. L. Moses: TGF-β and cell cycle regulation. Cancer Res., 55:1452-1457 (1995).
4. Attisano, L., J. L. Wrana, F. Lopez-Casillas, and J. Massague: TGF-β receptors and actions. Biochim. Biophys. Acta, 1222:71-80 (1994).
5. Battegay, E. J., E. W. Raines, R. A. Seifert, D. F. Bowen-Pope, and R. Ross: TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell, 63:515-524 (1990).
6. Bernstein, S. H., S. M. Kharbanda, M. L. Sherman, V. P. Sukhatme, and D. W. Kufe: Posttranscriptional regulation of the zinc finger-encoding EGR-1 gene by GMCSF in human U-937 monocytic leukemia cells: involvement of a pertussis toxin-sensitive G protein. Cell Growth Diff., 2:273-278 (1991).
7. Bhandari, B., U. O. Wenzel, F. Marra, and H. E. Abboud: A nuclear protein in mesangial cells that binds to the promoter region of the PDGF-A chain gene. Induction by TPA. J. Biol. Chem., 270:5541-5548 (1995).
8. Blessing, M., L. B. Nanney, L. E. King, C. M. Jones, and B. L. Hogan: Transgenic mice as a model to study the role of TGF-β-related molecules in hair follicles. Genes Devel., 7:204-215 (1993).
9. Blok, L. J., M. E. Grossmann, J. E. Perry, and D. J. Tindall: Characterization of an early growth response gene, which encodes a zinc finger transcription factor, potentially involved in cell cycle regulation. Mol. Endo., 9:1610-1620 (1995).
10. Biesiada, E., M. Razandi, and E. R. Levin: Egr-1 activates basic fibroblast growth factor transcription mechanistic implications for astrocyte proliferation. J. Biol. Chem., 271:18576-18581 (1996).
11. Bonner, J. C., A. Badgett, P. M. Lindroos, and A. R. Osornio-Vargas: TGF β1 downregulates the PDGF α-receptor subtype on human lung fibroblasts in vitro. Am. J. Resp. Cell Mol. Biol., 13:496-505 (1995).
12. Briggs, M. R., J. T. Kadonaga, S. P. Bell, and R. Tjian: Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science, 234:47-52 (1986).
13. Bronner G., Q. Chu-LaGraff, C. Q. Doe, B. Cohen, D. Weigel, H. Traubert, and H. Jackle: Sp1/Egr-1-like zinc-finger protein required for endoderm specification and germ-layer formation in Drosophila. Nature, 369:664-668 (1994).
14. Bruening, W., P. Gross, T. Sato, J. Stanimir, Y. Nakamura, D. Housman, and J. Pelletier: Analysis of the 11p13 Wilms' tumor suppressor gene (WT1) in ovarian rumors. Cancer Invest., 11:393-399 (1993).
15. Call, K. M., T. Glaser, C. Y. Ito, A. J. Buckler, J. Pelletier, D. A. Haber, E. A. Rose, A. Kral, H. Yeger, W. H. Lewis, C. Jones, and D. E. Housman: Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell, 60:509-520 (1990).
16. Calogero, A., L. Cuomo, M. D'Onofrio, U. de Grazia, P. Spinsanti, D. Mercola, A. Faggioni, L. Frati, E. D. Adamson, and G. Ragona: Expression of EGR-1 correlation with the transformed phenotype and the type of viral latency in EBV genome positive lymphoid cell lines. Oncogene, 13:2105-2112 (1996).
17. Cao, X., R. A. Koski, A. Gashler, M. McKiernan, C. F. Morris, R. Gaffney, R. V. Hay, and V. P. Sukhatme: Identification and characterization of the Egr-1 gene product, a DNA-binding zinc finger protein induced by differentiation and growth signals. Mol. Cell. Biol., 10:1931-1939 (1990).
18. Cao, X., R. Mahendran, G. R. Guy, and Y. H. Tan: Protein phosphatase inhibitors induce the sustained expression of the Egr-1 gene and the hyperphosphorylation of its gene product. J. Biol. Chem., 267:12991-12997 (1992).
19. Cao, X., R. Mahendran, G. R. Guy, and Y. H. Tan: Detection and characterization of cellular EGR-1 binding to its recognition site. J. Biol. Chem., 268:16949-16957 (1993).
20. Changelian, P. S., P. Feng, T. C. King, and J. Milbrandt: Structure of the NGFI-A gene and detection of upstream sequences responsible for its transcriptional induction by nerve growth factor. Proc. Natl. Acad. Sci. U.S.A., 86:377-381 (1989).
21. 1 transition in cultured cells. EMBO J., 7:29-35 (1988).
22. Chavrier, P., C. Vesque, B. Galliot, M. Vigneron, P. Dolle, D. Duboule, and P. Charnay: The segment-specific gene Krox-20 encodes a transcription factor with binding sites in the promoter region of the Hox-1.4 gene. EMBO J., 9:1209-1218 (1990).
23. Chen, X., J. C. Azizkhan, and D. C. Lee: The binding of transcription factor Sp1 to multiple sites is required for maximal expression from the rat transforming growth factor a promoter. Oncogene, 7:1805-1815 (1992).
24. Chen, X., K. L. Wright, E. A. Berkowitz, J. C. Azizkhan, J. P.-Y. Ting, and D. C. Lee: Protein interactions at Sp-1 like sites in the TGF α promoter as visualized by in vivo genomic footprinting. Oncogene, 9:3179-3187 (1994).
25. Christy, B. and D. Nathans: Functional serum response elements upstrem of the growth factor-inducible gene Zif268. Mol. Cell. Biol., 9:4889-4895 (1989).
26. Christy, B., L. K. Sanders, L. F. Lau, N. G. Copeland, N. A. Jenkins, and D. Nathans: An Id-related helix-loop-helix protein encoded by a growth factor-inducible gene. Proc. Natl. Acad. Sci. U.S.A. 88:1815-1819 (1991).
27. Cornwell, M. M. and D. E. Smith: Sp1 activates the MDR1 promoter through one of two distinct G-rich regions that modulate promoter activity. J. Biol. Chem., 268:19505-19511 (1993).
28. Crosby, S. D., J. J. Puetz, K. S. Simburger, T. J. Fahrner, and J. Milbrandt: The early response gene NGFI-C encodes a zinc finger transcriptional activator and is a member of the GCGGGGGCG (GSG) element-binding protein family. Mol. Cell. Biol., 11:3835-3841 (1991).
29. Cui, M.-Z., G. C. N. Parry, P. Oeth, H. Larson, M. Smith, R.-P. Huang, E. D. Adamson, and N. Meckman: Transcriptional regulation of the tissue factor gene in human epithelial cells is mediated by Sp1 and EGR-1. J. Biol. Chem., 271:2731-2739 (1996).
30. Danielpour, D., L. L. Dart, K. G. Flanders, A. B. Roberts, and M. B. Sporn: Immunodetection and quantitation of the two forms of TGF-β (-β 1 and -β 2) secreted by cells in culture. J. Cell. Physiol., 138:79-86 (1989).
31. Darland, T., M. Samuels, S. A. Edwards, V. P. Sukhatme, and E. D. Adamson: Regulation of Egr-1 (Zfp-6) and c-fos expression in differentiating embryonal carcinoma cells. Oncogene, 6:1367-1376 (1991).
32. Datto, M. B., Y. Yu, and X. F. Wang: Functional analysis of the TGF-β-responsive elements in the WAF1/Cip1/p21 promoter. J. Biol. Chem. 270:28623-28628 (1995).
33. Denny P. and A. Ashworth: A zinc finger protein-encoding gene expressed in the post-meiotic phase of spermatogenesis. Gene, 106:221-227 (1991).
34. Dey, B. R., V. P. Sukhatme, A. B. Roberts, M. B. Sporn, F. J. Rauscher III, and S.-J. Kim: Repression of the TGF-β 1 gene by the Wilms' tumor suppressor WT1 gene product. Mol. Endoc., 8:595-602 (1994).
35. Dickson, M. C., J. S. Martin, F. M. Cousins, A. B. Kulkarni, S. Karlsson, and R. J. Akhurst: Defective hematopoiesis and vasculogenesis in TGF-β 1 knock out mice. Development, 121:1845-1854 (1995).
36. Dirks, Ron P. H., H. J. Jansen, B. vanGerven, C. Onnekink, and Henri P. J. Bloemers: In vivo footprinting and functional analysis of the human c-sis/PDGF B gene promoter provides evidence for two binding sites for transcriptional activators. Nucl. Acid Res., 23:1119-1126 (1995).
37. Drummond, I. A., S. L. Madden, P. Rohwer-Nutter, G. I. Bell, V. P. Sukhatme, and F. J. Rauscher III: Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science, 257:674-678 (1992).
38. Ebert, S. N. and D. L. Wong: Differential activation of the rat phenylethanolamine N-methyltransferase gene by Sp1 and Egr-1. J. Biol. Chem., 270:17299-17305 (1995).
39. Eblen, S. T., M. P. Fautsch, R. J. Burnette, P. Joshi, and E. B. Leof: Cell cycle-dependent inhibition of p34cdc2 synthesis by TGF β 1 in cycling epithelial cells. Cell Growth Diff., 5:109-116 (1994).
40. Englert, C., X. Hou, S. Maheswaran, P. Bennett, C. Ngwu, A. J. Garvin, M. R. Rosner, and D. A. Haber: WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J., 14:4662-4675 (1995).
41. Ewen, M. E., H. K. Sluss, L. L. Whitehouse, and D. M. Livington: TGF β inhibition of cdk4 synthesis is linked to cell cycle arrest. Cell, 73:487-497 (1993).
42. Fang, F., G. Orend, N. Watanabe, T. Hunter, and E. Ruoslahti: Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science, 271:499-502 (1996).
43. Feng, X., E. H. Filvaroff, and R. Derynck: Transforming growth factor-β (TGF-β)-induced downregulation of Cyclin A expression requires a functional TGF-β receptor complex. J. Biol. Chem., 270:24237-24245 (1995).
44. SRF causes the aberrant induction of cellular immediate early genes through CArG boxes. Genes Devel., 6:2066-2076 (1992).
45. Fynan, T. M. and M. Reiss: Resistance to inhibition of cell growth by TGF-β and its role in oncogenesis. Crit. Rev. Oncogen., 4:493-540 (1993).
46. Galéra, P., M. Musso, P. Ducy, and G. Karsenty: c-Krox, a transcriptional regulator of type I collagen gene expression, is preferentially expressed in skin. Proc. Natl. Acad. Sci. U.S.A., 91:9372-9376 (1994).
47. Gashler, A. L., D. T. Bonthron, S. L. Madden, F. J. Rauscher III, T. Collins, and V. P. Sukhatme: Human PDGF A chain is transcriptionally repressed by the Wilms tumor suppressor WT1. Proc. Natl. Acad. Sci. U.S.A., 89:10984-10988 (1992).
48. Gashler, A. L., S. Swaminathan, and V. P. Sukhatme: A novel repression module, an extensive activation domain, and a bipartite nuclear localization signal defined in the immediate-early transcription factor Egr-1. Mol. Cell. Biol., 13:4556-4571 (1993).
49. Gashler, A. L. and V. P. Sukhatme: EGR protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog. Nucl. Acid Res. Mol. Biol., 50:191-224 (1995).
50. Geiser, A. G., S. J. Kim, A. B. Roberts, and M. B. Sporn: Characterization of the mouse transforming growth factor-beta 1 promoter and activation by the Ha-ras oncogene. Mol. Cell. Biol., 11:84-92 (1991).
51. Grover-Bardwick, A., E. Adamson, and D. Mercola: Transformation-specific pattern of phosphorylation of c-jun, jun-B, jun-D and Egr-1 in v-sis transformed cells. Carcinogenesis, 15:1667-1674 (1994).
52. Gunther, M., T. Frebourg, M. Laithier, N. Fossar, M. Bouziane-Ouartini, C. Lavialle, and O. Brison: An Sp1 binding site and the minimal promoter contribute to overexpression of the cytokeratin 18 gene in tumorigenic clones relative to that in nontumorigenic clones of a human carcinoma cell line. Mol. Cell. Biol., 15:2490-2499 (1995).
53. Gupta, M. P., M. Gupta, R. Zak, and V. P. Sukhatme: Egr-1, a serum-inducible zinc finger protein, regulates transcription of the rat cardiac a-myosin heavy chain gene. J. Biol. Chem., 266:12813-12816 (1991).
54. Haber, D. A. and A. J. Buckler: WT1: a novel tumor suppressor gene inactivated in Wilms' tumor. New Biol., 4:97-106 (1992).
55. Hahn, S. A., M. Schutte, S. A. T. Hoque, C. A. Moskaluk, L. T. da Costa, E. Rozenblum, C. L. Weinstein, A. Fischer, C. J. Yeo, and R. H. Hruban et al.: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science, 271:350-353 (1996).
56. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature, 371:257-261 (1994).
57. Harrington, M. A., B. Kyonicek, A. Song, X. L. Xia, W. J. Fredericks, and F. J. Rauscher III: Inhibition of CSF-1 promoter activity by the product of the Wilms' tumor locus. J. Biol. Chem., 268:21271-21275 (1993).
58. Herschman, H. R.: Primary response genes induced by growth factors and tumor promoters. Annu. Rev. Biochem., 60:281-319 (1991).
59. Hewitt, S. M., G. C. Fraizer, Y.-J. Wu, F. J. Rauscher III, and G. F. Saunders: Differential function of Wilms' tumor gene WT1 splice isoforms in transcriptional regulation. J. Biol. Chem., 271:8588-8592 (1996).
60. Hofmann, W., H.-D. Royer, M. Drechsler, S. Schneider, and B. Royer-Pokora: Characterization of the transcriptional regulatory region of the human WT1 gene. Oncogene, 8:3123-3132 (1993).
61. Honkaniemi, J., J. Kononen, T. Kainu, I. Pyykonen, and M. Pelto-Huikko: Induction of multiple immediate early genes in rat hypothalamic paraventricular nucleus after stress. Brain Res. Mol. Brain Res., 25:234-241 (1994).
62. Honkaniemi, J., S. M. Sagar, I. Pyykonen, K. J. Hicks, and F. R. Sharp: Focal brain injury induces multiple immediate early genes encoding zinc finger transcription factors. Brain Res. Mol. Brain Res., 28:157-163 (1995).
63. 1/S-phase growth arrest. Mol. Cell. Biol., 11:1185-1194 (1991).
64. Huang, R.-P., T. Darland, D. Okumura, D. Mercola, and E. Adamson: Suppression of v-sis-dependent transformmation by the transcription factor, EGR.-1. Oncogene, 9:1367-1377 (1994).
65. Huang, R.-P., C.-T. Liu, Y. Fan, D. Mercola, and E. D. Adamson: EGR-1 Negatively regulates human tumor cell growth via the DNA-binding domain. Cancer Res., 55:5054-5062 (1995).
66. Huang, R-P., Y. Fan, D. Mercola, and E. Adamson: Facilitated inhibition of Sp1 activity by Egr-1 (manuscript in preparation).
67. Hyun, S. W., K. Park, Y. S. Lee, Y. I. Lee, and S.-J. Kim: Inhibition of protein phosphatases activates P4 promoter of the human insulin-like growth factor II gene through the specific promoter element. J. Biol. Chem., 269:364-368 (1994).
68. Imataka, H., K. Sogawa, K. Yasumoto, Y. Kikuchi, K. Sasano, A. Kobayashi, M. Hayami, and Y. Fujii-Kuriyama: Two regulatory proteins that bind to the basic transcription element (BTE), a GC box sequence in the promoter region of the rat P-4501A1 gene. EMBO J., 11:3663-3671 (1992).
69. Jhappan, C., A. G. Geiser, E. C. Kordon, D. Bagheri, L. Hennighausen, A. B. Roberts, G. H. Smith, and G. Merlino: Targeting expression of a TGF β 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. EMBO J., 12:1835-1845 (1993).
70. Joseph, L. J., M. M. Le Beau, G. A. Jamieson, Jr., S. Acharya, T. B. Shows, J. D. Rowley, and V. P. Sukhatme: Molecular cloning, sequencing, and mapping of EGR2, a human early growth response gene encoding a protein with "zinc-binding finger" structure (published erratum appears in Proc. Natl. Acad. Sci. U.S.A., 86:515 [1989]). Proc. Natl. Acad. Sci. U.S.A., 85:7164-7168 (1989).
71. Joseph, L. J., M. M. Le Beau, G. A. Jamieson, Jr., S. Acharya, T. B. Shows, J. D. Rowley, and V. P. Sukhatme: Molecular cloning, sequencing, and mapping of EGR2, a human early growth response gene encoding a protein with "zinc-binding finger" structure (published erratum appears in Proc. Natl. Acad. Sci. U.S.A., 86:515 [1989]). Proc. Natl. Acad. Sci. U.S.A., 85:7164-7168 (1989).
72. Kadonaga, J. T., K. R. Carner, F. R. Masiarz, and R. Tjian: Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell, 51:1079-1090 (1987).
73. Kaetzel, D. M., F. S. Maul, B. Liu, D. Bonthron, R. A. Fenstermaker, and D. W. Coyne: PDGF A-chain gene transcription is mediated by positive and negative regulatory regions in the promoter. Biochem. J., 301:321-327 (1994).
74. Kageyama, R., G. T. Merlino, and I. Pastan: Epidermal growth factor (EGF) receptor gene transcription: requirement for Sp1 and an EGF receptor-specific factor. J. Biol. Chem., 263:6326-6329 (1988).
75. Kalkhoven, E., B. A. Roelen, J. P. de Winter, C. L. Mummery, A. J. van den Eijnden-van Raaij, P. T. van der Saag, and B. van der Burg: Resistance to TGF-β and activin due to reduced receptor expression in human breast tumor cell lines. Cell Grow. Diff., 6:1151-1161 (1995).
76. Kalkhoven, E., E. Beraldi, M. L. Panno, J. P. De Winter, H. H. Thijssen, and B. Van der Burg: Growth inhibition by anit-estrogens and progestins in TGF-β-resistant and -sensitive breast tumor cells. Int. J. Cancer, 65:682-687 (1996).
77. Khachigian, L. M., A. J. Williams, and T. Collins: Interplay of Sp1 and Egr-1 in the proximal PDGF A-chain promoter in cultured vascular endothelial cells. J. Biol. Chem., 270:27679-27686 (1995).
78. Khachigian, L. M., B. Lindner, A. J. Williams, and T. Collins: Egr-1-Induced endothelial gene expression: a common theme in vascular injury. Science, 271:1427-1431 (1996).
79. Kharbanda, S., T. Nakamura, R. Stone, R. Hass, S. Bernstein, R. Datta, V. P. Sukhatme, and D. Kufe: Expression of the early growth response 1 and 2 zinc finger genes during induction of monocytic differentiation. J. Clin. Invest., 88:571-577 (1991).
80. Kilbourne, E. J., R. Widom, D. C. Harnish, S. Malik, and S. K. Karathanasis: Involvement of early growth response factor Egr-1 in apolipoprotein AI gene transcription. J. Biol. Chem., 270:7004-7010 (1995).
81. Kim, I. Y., H.-J. Ahn, D. J. Zelner, J. W. Shaw, J. A. Sensibar, J.-H. Kim, K. Mitsuyasu, and C. Lee: Genetic change in TGF-β receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells. Canc. Res. 56:44-48 (1996).
82. Kim, S. J., K. Park, B. B. Rudkin, B. R. Dey, M. B. Sporn, and A. B. Roberts: Nerve growth factor induces transcription of transformation growth factor-beta 1 through a specific promoter element in PC12 cells. J. Biol. Chem., 269:3739-3744 (1994).
83. Kinane, T. B., J. D. Finder, A. Kawashima, D. Brown, M. Abbate, C. Shang, W. J. Fredericks, F. J. Rauscher III, V. P. Sukhatme, and L. Ercolani: Growth of LLC-PK1 renal cells is mediated by EGR-1 upregulation of G protein alpha i-2 protooncogene transcription. J. Biol. Chem., 269:27503-27509 (1994).
84. Kinane, T. B., J. D. Finder, A. Kawashima, D. Brown, M. Abbate, W. J. Fredericks, V. P. Sukhatme, F. J. Rauscher III, and L. Ercolani: LLC-PK1 cell growth is repressed by WT1 inhibition of G-protein alpha i-2 protooncogene transcription. J. Biol. Chem., 270:30760-30764 (1995).
85. Kingsley, C. and A. Winoto: Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression. Mol. Cell. Biol., 12:4251-4261 (1992).
86. Konig, A., S. Jacubicska, P. Wieacker, H. W. Shlösser, and M. Gessler: Further evidence that imbalance of WT1 isoforms may be involved in Denys-Drash syndrome. Hum. Mol. Genet., 2:1967-1968 (1993).
87. Kramer, B., A. Meichle, G. Hensel, P. Charnay, and M. Kronke: Characterization of an krox-24/Egr-1-responsive element in the human tumor necrosis factor promoter. Biochim. Biophys. Acta, 1219:413-421 (1994).
88. Krishnaraju, K., H. Q. Nguyen, D. A. Liebermann, and B. Hoffman: The zinc finger transcription factor Egr-1 potentiates macrophage differentiation of hematopoietic cells. Mol. Cell. Biol., 15:5499-5507 (1995).
89. Le Beau, M. M., R. Espinosa III, W. L. Neuman, W. Stock, D. Roulston, R. A. Larson, M. Keinanen, and C. A. Westbrook: Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proc. Natl. Acad. Sci. U.S.A., 90:5484-5488 (1993).
90. Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev., 9:639-649 (1995).
91. Lee, S. L., L. C. Tourtellotte, R. L. Wesselschmidt, and J. Milbrandt: Growth and differentiation proceeds normally in cells deficient in the immediate early gene NGFI-A. J. Biol. Chem., 270:9971-9977 (1995).
92. Lee, S. L., A. Sadovsky, A. H. Swirnoff, J. A. Polish, P. Goda, G.Gavrilina, and J. Milbrandt: Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGFI-A (Egr-1). Science, 273:1219-1221 (1996).
93. Lemaire, P., C. Vesque, J. Schmitt, H. Stunnenberg, R. Frank, and P. Charnay: The serum-inducible mouse gene Krox-24 encodes a sequence-specific transcriptional activator. Mol. Cell. Biol. 10:3456-3467 (1990).
94. Levin, W. J., M. F. Press, R. B. Gaynor, V. P. Sukhatme, T. C. Boone, P. T. Reissmann, R. A. Figlin, E. C. Holmes, L. M. Souza, and D. J. Slamon: Expression patterns of immediate early transcription factors in human non-small cell lung cancer. Oncogene, 11:1261-1269 (1995).
95. INK4B through an Sp1 consensus site. J. Biol. Chem., 270:26750-26753 (1995).
96. Li, Y., S. Camp, T. L. Rachinsky, C. Bongiorno, and P. Taylor: Promoter element and transcriptional control of the mouse acetylcholinesterase gene. J. Biol. Chem. 268:3563-3572 (1993).
97. Liu, C.-T., E. D. Adamson, and D. Mercola: The transcription factor EGR-1 suppresses the growth and transformation of HT-1080 fibrosarcoma cells by induction of transforming growth factor β-1. Proc. Natl. Acad. Sci. U.S.A., 93: 11831-11836 (1996).
98. Liu, J., M. Shoyab, and R. I. Grove: Induction of Egr-1 by oncostatin M precedes upregulation of low-density lipoprotein receptors in HepG2 cells. Cell Growth Diff., 4:611-616 (1993).
99. Cip1. Nature, 375:159-161 (1995).
100. Luo, X. N., J. C. Reddy, P. L. Yeyati, A. H. Idris, S. Hosono, D. A. Haber, J. D. Licht, and G. F. Atweh: The tumor suppressor gene WT1 inhibits ras-mediated transformation. Oncogene, 11:743-750 (1995).
101. Mack, K. J., S. D. Yi, S. Chang, N. Millan, and P. Mack: NGFI-C expression is affected by physiological stimulation and seizure in the somatosensory cortex. Brain Res. Mol. Brain Res., 29:140-146 (1995).
102. Madden, S. L., D. M. Cook, J. F. Morris, A. Gashler, V. P. Sukhatme, and F. J. Rauscher III: Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science, 253:1550-1553 (1991).
103. Madden, S. L. and F. J. Rauscher III: Positive and negative regulation of transcription and cell growth mediated by the EGR family of zinc-finger gene products. Annal. N.Y. Acad. Sci., 684:75-84 (1993).
104. Madden S. L., D. M. Cook, and F. J. Rauscher III: A structure-function analysis of transcriptional repression mediated by the WT1, Wilms' tumor suppressor protein. Oncogene, 8:1713-1720 (1993).
105. Maheswaran, S., S. Park, A. Bernard, J. F. Morris, F. J. Rauscher, D. E. Hill, and D. A. Haber: Physical and functional interaction between WT1 and P53 proteins. Proc. Natl. Acad. Sci. U.S.A., 90:5100-5104 (1993).
106. Majack, R. A., M. W. Majesky, and L. V. Goodman: Role of PDGF-A expression in the control of vascular smooth muscle cell growth by TGF-β. J. Cell Biol., 111:239-247 (1990).
107. Markowitz, S., J. Wang, L. Myeroff, P. Parsons, L. Sun, H. Lutterbaugh, R. S. Far, E. Zborowska, K. W. Kinzler, B. Vogelstein, M. Brattain, and J. K. V. Wilson: Inactivation of the type II TGF-β receptor colon cancer cells with microsatellite instability. Science, 268:1336-1338 (1996).
108. Martin, J. S., M. C. Dickson, F. M. Cousins, A. B. Kulkarni, S. Karlsson, and R. J. Akhurst: Analysis of homozygous TGF β 1 null mouse embryos demonstrates defects in yolk sac vasculogenesis and hematopoiesis. Annal. N.Y. Acad. Sci., 752:300-308 (1995).
109. Menke, A. L., N. Riteco, R. C. van Ham, C. de Bruyne, F. J. Rauscher III, A. J. van der Eb, and A. G. Jochemsen: Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells. Oncogene, 12:537-546 (1996).
110. Missero, C., C. Serra, K. Stenn, and G. P. Dotto: Skin-specific expression of a truncated E1a oncoprotein binding to p105-Rb leads to abnormal hair follicle maturation without increased epidermal proliferation. J. Cell Biol., 121:1109-1120 (1993).
111. 1 transition of the cell cycle. Mol. Cell. Biol., 14:5242-5248 (1994).
112. Momand, J., G. P. Zambetti, D. C. Olson, D. George, and A. J. Levine: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69:1237-1245 (1992).
113. Mutero, A., S. Camp, and P. Taylor: Promoter element of the mouse acetylcholinesterase gene transcriptional regulation during muscle differentiation. J. Biol. Chem., 270:1866-1872 (1995).
114. Muthukkumar, S., P. Nair, S. F. Sells, N. G. Maddiwar, R. J. Jacob, and V. M. Rangnedar: Role of EGR-1 in thapsigargin-inducible apoptosis in the melanoma cell line A375-C6. Mol. Cell. Biol., 15:6262-6272 (1995).
115. Nabel, E. G., L. Shum, V. J. Pompili, Z.-Y. Yang, H. San, H.-B. Shu, S. Liptay, L. Gold, D. Gordon, R. Derynck et al.: Direct transfer of TGF β1 gene into arteries stimulates fibrocellular hyperplasia. Proc. Natl. Acad. Sci. U.S.A., 90:10759-10763 (1993).
116. Nakagama, H., G. Heinrich, J. Pelletier, and D. E. Housman: Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product. Mol. Cell. Biol., 15:1489-1498 (1995).
117. Nguyen, H. Q., B. Hoffman-Liebermann, and D. A. Liebermann: The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage. Cell, 72:197-209 (1993).
118. Oates, T. W., K. N. Kose, J. F. Xie, D. T. Graves, J. M. Collins, and D. L. Cochran: Receptor binding of PDGF-AA and PDGF-BB and the modulation of PDGF receptors by TGF-β in human periodontal ligament cells. J. Cell. Physiol., 162:359-366 (1995).
119. Park, S., G. Tomlinson, P. Nisen, and D. A. Haber: Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated wilms' tumor. Cancer Res., 53:4757-4760 (1993).
120. Park, K., S.-J. Kim, Y.-J. Bang, J. G. Park, N.-K. Kim, A. B. Roberts, and M. B. Sporn: Genetic changes in the TGF β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc. Natl. Acad. Sci. U.S.A., 91:8772-8776 (1994).
121. Patwardhan, S., A. Gashler, M. G. Siegel, L. C. Chang, L. J. Joseph, T. B. Shows, M. M. Le Beau, and V. P. Sukhatme: EGR3, a novel member of the Egr family of genes encoding immediate-early transcription factors. Oncogene, 6:917-928 (1991).
122. Paulsson, Y., C. Karlsson, C. H. Heldin, and B. Westermark: Density-dependent inhibitory effect of TGF-β 1 on human fibroblasts involves the downregulation of PDGF alpha-receptors. J. Cell Phys., 157:97-103 (1993).
123. Pavletich, N. P. and C. O. Pabo: Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A. Science, 252:809-817 (1991).
124. Pierce, D. F., Jr., M. D. Johnson, Y. Matsui, S. D. Robinson, L. I. Gold, A. F. Purchio, C. W. Daniel, B. L. Hogan, and H. L. Moses: Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-β 1. Genes Devel., 7:2308-2317 (1993).
125. Pierce, D. F., Jr., A. E. Gorska, A. Chytil, K. S. Meise, D. L. Page, R. J. Coffey, Jr., and H. L. Moses: Mammary tumor suppression by TGF β 1 transgene expression. Proc. Natl. Acad. Sci. U.S.A. 92:4254-4258 (1995).
126. Kip1, a cyclin-cdk inhibitor, links TGF-β and contact inhibition to cell cycle arrest. Genes Dev., 8:9-22 (1994).
127. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78:59-66 (1994).
128. Rauscher III, F. J.: The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J., 7:896-903 (1993).
129. Roberts, A. B. and M. B. Sporn: Physiological actions and clinical application of TGF-β. Growth Factors, 8:1-9 (1993).
130. Roche, N. S., A. B. Roberts, and D. R. Roop: Inhibition of skin development by overexpression of TGF β 1 in the epidermis of transgenic mice. Proc. Natl. Acad. Sci. U.S.A., 90:5237-5241 (1990).
131. Russo, M. W., C. Matheny, and J. Milbrandt: Transcriptional activity of the zinc finger protein NGFI-A is influenced by its interaction with a cellular factor. Mol. Cell. Biol., 13:6858-6865 (1993).
132. Russo, M. W., B. R. Sevetson, and J. Milbrandt: Identification of NAB1, a represser of NGFI-A- and Krox20-mediated transcription. Proc. Natl. Acad. Sci. U.S.A., 92:6873-6877 (1995).
133. Sakamoto, K. M., C. Bardeleben, K. E. Yates, M. A. Raines, D. W. Golde, and J. C. Gasson: 5′ upstream sequence and genomic structure of the human primary response gene, EGR-1/TIS8. Oncogene, 6:867-871 (1991).
134. Sakamoto, K. M., S. D. Nimer, J. D. Rosenblatt, and J. C. Gasson: HTLV-I and HTLV-II tax trans-activate the human EGR-1 promoter through different cis-acting sequences. Oncogene, 7:2125-2130 (1992).
135. Schneider-Maunoury S., P. Topiko, T. Seitanidou, G. Levi, M. Cohen-Tannoudji, S. Pournin, C. Babinet, and P. Charnay: Disruption of krox-20 results in alteration of rhombomeres 3 and 5 in the developing hindbrain. Cell, 75:1199-1214 (1993).
136. Seifert, R. A., S. A. Coats, E. W. Raines, R. Ross, and D. F. Bowen-Pope: PDGF receptor alpha-subunit mutant and reconstituted cell lines demonstrate that TGF-β can be mitogenic through PDGF A-chain-dependent and -independent pathways. J. Biol. Chem., 269:13951-13955 (1994).
137. Shingu, T. and P. Bornstein: Overlapping Egr-1 and Sp1 sites function in the regulation of transcription of the mouse thrombospondin 1 gene. J. Biol. Chem., 269:32551-32557 (1994).
138. Skerka, C., E. L. Decker, and P. F. Zipfel: A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger protein Sp1 and EGR-1. J. Biol. Chem., 270:22500-22506 (1995).
139. Sogawa K., H. Imataka, Y. Yamasaki, H. Kusume, H. Abe, and Y. Fujii-Kuriyama: cDNA cloning and transcriptional properties of a novel GC box-binding protein, BTEB2. Nucl. Acid Res., 21:1527-1532 (1993).
140. Stouffer, G. A. and G. K. Owens: TGF-β promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms. J. Clin. Invest., 93:2048-2055 (1994).
141. Sukhatme, V. P., X. Cao, L. C. Chang, C. H. Tsai-Morris, D. Stamenkovich, P. C. Ferreira, D. R. Cohen, S. A. Edwards, T. B. Shows, T. Curran et al.: A zinc finger-encoding gene coregulated with c-fos during growth and differentiation and after cellular depolarization. Cell, 53:37-43 (1988).
142. Sukhatme, V. P.: The Egr transcription factor family: from signal transduction to kidney differentiation. Kidney Int., 41:550-553 (1992).
143. Sun, L., G. Wu, J. K. Willson, E. Zborowska, J. Yang, I. Rajkarunanayake, J. Wang, L. E. Gentry, X. F. Wang, and M. G. Brattain: Expression of TGF β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J. Biol. Chem., 269:26449-26455 (1994).
144. Svaren, J., B. R. Sevetson, E. D. Apel, D. B. Zimonjic, N. C. Popescu, and J. Milbrandt: NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli. Mol. Cell. Biol., 16:3545-3553 (1996).
145. Swirnoff, A. H. and J. Milbrandt: DNA-binding specificity of NGFI-A and related zinc finger transcription factors. Mol. Cell. Biol., 15:2275-2287 (1995).
146. Topilko, P., S. Schneider-Maunoury, G. Levi, A. B. Evercooren, A. Ben Younes Chennoufi, T. Seitanidou, C. Babinet, and P. Charnay: Krox-20 controls myelination in the peripheral nervous system. Nature, 371:796-799 (1994).
147. Varnum, B. C., R. W. Lim, D. A. Kujubu, S. J. Luner, S. E. Kaufman, J. S. Greenberger, J. C. Gasson, and H. R. Herschman: GM-CSF and tetradecanoyl phorbol acetate induce a distinct, restricted subset of primary-response TIS genes in both proliferating and terminally differentiated myeloid cells. Mol. Cell. Biol., 9:3580-3583 (1989).
148. Wang, J., L. Sun, L. Myeroff, X. Wang, L. E. Gentry, J. Yang, J. Liang, E. Zborowska, S. Markowitz, and J. K. Willson et al.: Demonstration that mutation of the type II TGF β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J. Biol. Chem., 270:22044-22049 (1995).
149. Wang, Z.-Y. and T. F. Deuel: An S1 nuclease-sensitive homopurine/homopyrimidine domain in the PDGF A-chain promoter contains a novel binding site for the growth factor-inducible protein EGR-1. Biochem. Biophys. Res. Comm., 188:433-434 (1992).
150. Wang, Z.-Y., S. L. Madden, T. F. Deuel, and F. J. Rauscher III: The Wilms' tumor gene product, WT1, represses transcription of the PDGF A-chain gene. J. Biol. Chem., 267:21999-22002 (1992).
151. Wang, Z.-Y., Q.-Q. Qiu, and T. F. Deuel: The Wilm's tumor gene product WT1 activates or suppresses transcription through separate functional domains. J. Biol. Chem., 268:9172-9175 (1993).
152. Wang, Z.-Y., Q.-Q. Qiu, K. T. Enger, and T. F. Deuel: A second transcriptionally active DNA-binding site for the Wilms' tumor gene product WT1. Proc. Natl. Acad. Sci. U.S.A., 90:8896-8900 (1993).
153. Wang, Z.-Y., N. Masaharu, Q.-Q. Qiu, Y. Takimoto, and T. F. Deuel: An S1 nuclease-sensitive region in the first intron of human platelet-derived growth factor A-chain gene contains a negatively acting cell type-specific regulatory element. Nucl. Acid Res., 22:457-464 (1994).
154. Wang, Z.-Y., Q.-Q. Qiu, J. Huang, M. Gurrieri, and T. F. Deuel: Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene WT1 have altered DNA binding specificity and regulate transcription in different ways. Oncogene, 10:415-422 (1995).
155. Wang, Z.-Y., Q.-Q. Qiu, M. Gurrieri, J. Huang, and T. F. Deuel: WT1, the Wilms' tumor suppressor gene product, represses transcription through an interactive nuclear protein. Oncogene, 10:1243-1247 (1995).
156. Watson, M. A. and J. Milbrandt: The NGFI-B gene, a transcriptionally inducible member of the steroid receptor gene superfamily: genomic structure and expression in rat brain after seizure induction. Mol. Cell. Biol., 9:4213-4219 (1989).
157. Werner, H., G. G. Re, I. A. Drummond, V. P. Sukhatme, F. J. Rauscher III, D. A. Sens, A. J. Garvin, D. LeRoith, and C. T. Roberts, Jr.: Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. Proc. Natl. Acad. Sci. U.S.A., 90:5828-5832 (1993).
158. Werner, H., Z. Shen-Orr, F. J. Rauscher III, J. F. Morris, C. T. Roberts, Jr., and D. LeRoith: Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression. Mol. Cell. Biol., 15:3516-3522 (1995).
159. Wimmer E. A., H. Jackle, C. Pfeifle, and S. M. Cohen: A Drosophila homologue of human Sp1 is a head-specific segmentation gene. Nature, 366:690-694 (1993).
160. Yoo, Y. D., H. Ueda, K. Park., K. C. Flanders, Y. I. Lee, G. Jay, and S. J. Kim: Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis. J. Clin. Invest., 97:388-395 (1996).